News
Web & Podcasts
What’s On
Show submenu for What’s On
Webinars
Events
About Us
Show submenu for About Us
Who We Are
Our Contributors
Advertise
Contact
News
Web & Podcasts
What’s On
Show submenu for What’s On
Webinars
Events
About Us
Show submenu for About Us
Who We Are
Our Contributors
Advertise
Contact
Neuren receives Rare Paediatric Disease Designation from FDA
Memphasys Eyes Breakthrough with New Oxidative Stress Measurement for Animal Reproduction
Opthea welcomes retina leaders to its Medical Advisory Board
Neurotech's Phase II/III autism trial shows further benefits
Next Science enters into US$5m unsecured loan facility
Immutep receives regulatory clearance for Phase 1 IMP761 trial
Zelira secures leading patents for HOPE 1 and HOPE 2
Spenda makes strategic acquisition of Limepay
Singular Health extends 3Dicom for Veterans initiative to Texas
Adisyn enters strategic collaboration with 2D Generation
Q&A With Dr David Ali From Memphasys Reproductive Biotechnology (ASX:MEM)
Staff Writers
12 June, 2023
Pharmaceuticals
SHARE
SHARE
Rate video from Staff Writers:
Related Videos & Media on TechInvest
29 September, 2023
Memphasys (ASX:MEM) Investor Webinar - 21 Sept 2023
Watch video
Innovation
3 April, 2023
Memphasys Limited ASX Announcement
Watch video